LANTERN PHARMA INC (LTRN)
US51654W1018 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 131.51% | N/A 43.49% | N/A 31.96% | |||||||
| EBITDA YoY % growth | N/A | -2.43M | -5.91M -143.21% | -12.58M -112.86% | -14.42M -14.63% | -17.863M -23.88% | N/A -79.87% | N/A -41.27% | N/A -25.17% | N/A -15.44% | N/A -9.18% | N/A 0.71% | N/A 18.51% | |
| EBIT YoY % growth | -1.73M | -2.43M -40.46% | -5.91M -143.21% | -12.59M -113.03% | -14.43M -14.61% | -17.878M -23.89% | N/A -25.14% | N/A -5.88% | N/A 19.96% | N/A -80.76% | N/A 38.10% | N/A 50.48% | N/A 115.53% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.13 16.07% | -1.31 -15.93% | -1.48 -12.98% | N/A -30.95% | N/A 2.11% | N/A 38.71% | N/A -12.28% | N/A 40.63% | N/A 55.26% | N/A 138.24% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.52 -33.38% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -5.726M -17.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.42 -44.83% | -0.57 | 0.15 | 26.47% |
| Q2 2024 Q2Q % growth | -0.46 -4.55% | -0.56 | 0.10 | 18.00% |
| Q1 2024 Q2Q % growth | -0.51 -41.67% | -0.44 | -0.07 | -16.28% |
| Q4 2023 Q2Q % growth | -0.39 -25.81% | -0.41 | 0.02 | 4.41% |
| Q3 2023 Q2Q % growth | -0.29 -38.10% | -0.46 | 0.17 | 37.51% |
| Q2 2023 Q2Q % growth | -0.44 -7.32% | -0.44 | 0.00 | 0.45% |
| Q1 2023 Q2Q % growth | -0.36 5.26% | -0.49 | 0.13 | 26.47% |
| Q4 2022 Q2Q % growth | -0.31 3.13% | -0.48 | 0.17 | 35.34% |
| Q3 2022 Q2Q % growth | -0.21 41.67% | -0.49 | 0.28 | 57.11% |
| Q2 2022 Q2Q % growth | -0.41 -95.24% | -0.53 | 0.12 | 22.70% |
| Q1 2022 Q2Q % growth | -0.38 -58.33% | -0.30 | -0.08 | -28.47% |
| Q4 2021 Q2Q % growth | -0.32 31.91% | -0.41 | 0.09 | 22.22% |
| Q3 2021 Q2Q % growth | -0.36 -33.33% | -0.27 | -0.09 | -32.35% |
| Q2 2021 Q2Q % growth | -0.21 | -0.27 | 0.06 | 20.81% |
| Q1 2021 Q2Q % growth | -0.24 | -0.28 | 0.04 | 12.85% |
| Q4 2020 Q2Q % growth | -0.47 | -0.46 | -0.01 | -1.64% |
| Q3 2020 Q2Q % growth | -0.27 | -0.34 | 0.07 | 20.59% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 15% | 0% | 10.38% |
| Revenue | N/A | N/A | N/A | N/A |